CIK 0002000775 · <br>Emerging growth company
Black Hawk Acquisition Corp
Sign in to watch- Ticker
- BKHA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Nov 30
- Entity type
- operating
- Phone
- 203-520-7122
- Business address
- 4125 BLACKHAWK PLAZA CIRCLE, SUITE 166, DANVILLE, CA, 94506
Securities
- BKHA Class A Ordinary Shares Nasdaq
- BKHAR Rights Nasdaq
- BKHAU Units Nasdaq
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- S-4/A Deal Registration Statement - Business Combination
- 10-K/A Report 10-K/A
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- 8-K Event Delisting notice
- 8-K Event Executive or director change · Regulation FD disclosure
- 10-K Report Annual Report
- S-4/A Deal Registration Statement - Business Combination
- NT 10-K Other NT 10-K
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale
- 8-K Event Executive or director change
- S-4/A Deal Registration Statement - Business Combination
- S-4/A Deal Registration Statement - Business Combination
- DEL AM Other DEL AM
- S-4 Deal Registration Statement - Business Combination
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 2 of 6 · 119 filings